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MS 1 - IMMUNOMODULATION AND IMMUNOTHERAPY
ANTIBODY RESPONSE AND IMMUNOTHERAPY IN DEEP
MYCOSIS: PRELIMINARY EXPERIENCE USING MONOCLONAL
ANTIBODIES IN PARACOCCIDIOIDOMYCOSIS.
Carlos P. Taborda,1 Rubens F. Buissa,1 Rosana Puccia2 and Luiz R. Travassos2
1Institute of Biomedical Sciences, Department of Microbiology, University of São Paulo, São
Paulo, SP, and 2Department of Microbiology, Immunology and Parasitology, Federal
University of São Paulo, São Paulo, SP, Brazil.
Background: Antibody-mediated immunity (AMI) was first described in 1890 by
Behring and Kitasato when they observed that the transfer of sera from an immunized to a
naïve host protected the latter against the effects of diphtheria and tetanus toxins. The
experiments by Behring and Kitasato defined the central procedure that is still being used
today for evaluating the efficacy of AMI (reviewed by Casadevall, A.- J. Immunol. Methods
291:1-10, 2004).
After being a central piece in the development of immunology in the early 20th century,
the study of the functional aspects of AMI declined in the 1960s. The role of antibodies was
taken as completely understood, and with the discovery of T cells, there was increased interest
on cell-mediated immunity, which with the rediscovery of innate immunity, steered
immunological research away from AMI. By the late 1980s, however, the development of
monoclonal antibody (mAb) technology, the discovery of Fc receptors, and generation of
mice with defined genetic deficiencies made possible studies that rekindled the interest on
the basic mechanisms of AMI (reviewed by Casadevall and Pirofski. Infect. Immun. 72:
6191-6196, 2004).
The relationship between antigen-specific immunoglobulin concentration and protection
remains poorly understood for the majority of pathogens. There is conclusive evidence,
however, that humoral immunity can modify the course of infection caused by some
pathogenic fungi. Immunotherapy studies, especially of cryptococcosis are most advanced.
C. neoformans has a polysaccharide capsule which is essential for its virulence, and mAbs
reactive with GXM can protect against experimental cryptococcosis. The efficacy of these
monoclonal antibodies against GXM is associated with several parameters such as isotype,
recognized epitope, dose and infective inoculum.
Antibodies in paracoccidioidomycosis (PCM) have been associated to severe disease,
whereas protection has always been attributed to cellular immune response. Mattos Grosso
et al., (Infect. Immun. 71: 6534-6542, 2003) showed that mAbs to gp70 abolished granuloma
formation in the lungs of mice intratracheally infected. In the present work a panel of mAbs
directed to peptide epitopes of the gp43 was evaluated in vivo.
Methods: Four anti-gp43 IgG2a mAbs (32H, 19G, 17D and 10D) and two IgG2b mAbs
(3E and 21F) were analyzed. As a control, an irrelevant mAb (A4) was used. Twenty four
hours before the mice were intratracheally infected with 3x105 yeast cells of Pb18, 1 mg of
mAb was injected intraperitoneally per animal. Groups of mice were sacrificed 15 and 30
days after the infection and colony forming units (CFU) from the lungs were counted.
Results: Significant reduction in the lung CFUs was observed after 15 days with all mAbs
tested with the exception of mAb 32H (IgG2a). However, after 30 days of infection, mAbs
19G and 10D (IgG 2a) and 3E (IgG 2b) were able to control the disease whereas mAbs 32H
and 17D (IgG2a) and 21F (IgG2b) caused a significant increase in the number of lung CFUs.
Discussion: Specific antibodies to a major antigen can be protective, nonprotective, or
disease enhancing depending on several factors and conditions. We show here that some
mAbs to gp43 were able to reduce CFUs from lungs of infected mice whereas others did not.
Data suggest that specific antibody responses can have a role in the immune protection against
PCM. A better understanding of the parameters that influence AMI can enhance our
understanding of vaccine efficacy and host susceptibility to infection.
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COMBINED P10 IMMUNIZATION AND CHEMOTHERAPY IN MICE
CHALLENGED INTRATRACHEALLY WITH PARACOCCIDIOIDES
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Introduction and Objectives: Previous work has shown that the major diagnostic
antigen of P. brasiliensis, the gp43, elicits a vigorous IFN-γ-mediated T-CD4+ response that
is protective against the intratracheal challenge by virulent yeasts of this fungus. The epitope
has been mapped to a 15-aa peptide (P10) that is presented by 3 MHC class II molecules
from different mouse haplotypes (Taborda et al., Infect. Immun., 66: 786-793, 1998). The
promiscuous nature of P10 was extended to human HLA-DR molecules, as it was shown
that this peptide and the analogous gp43 (180-194) without C-terminal asparagine
(glycosylation site in the original gp43) and with N-terminal lysine, bound to 9 most prevalent
HLA-DR molecules. Furthermore, 4 additional peptides from gp43 were also promiscuous
with respect to HLA-DR binding. The gp43 (180-194) was recognized by 53% of patients
with treated PCM and the other promiscuous peptides were recognized by 32% to 47% of
patients; 74% of patients recognized the combination of 5 promiscuous gp43 peptides (Iwai
et al., Molecular Medicine, 9: 209-219, 2003). (for 30 days every 24 h). These results are the
basis for devising a peptide vaccine against PCM that could be used as an adjuvant to
chemotherapy.
The demonstration that peptide immunization and chemotherapy combined confer
increased protection in experimental PCM is a necessary step in this study. Presently, we
used P10 immunization along with amphotericin B, ketoconazole, fluconazole, itraconazole,
sulphamethoxazole and sulphametoxazole/trimethoprim (5:1) treatment to evaluate the
protection against Pb infection in mice.
Methods: Two different protocols were used. After intratracheal infection of male Balb/
c mice with 3 x 105 yeast cells, drug treatment (for 30 days every 24 h) was started after 48h
or after 30 days of i.t. infection. One group of animals was infected and treated with drugs
and another was, in addition, also weekly immunized with 20 µg P10, first subcutaneously
in complete, and then i.p. in incomplete, Freund´s adjuvant. Mice were sacrificed 30 and 90
days or 60 and 120 days after i.t. infection, and the fungal burden measured as lung, liver
and spleen CFUs. Organ homogenates were also assayed for IL-2, IL-4, IL-10, IL-12,
TNF-α and IFN-γ using ELISA kits. Lungs were examined for histopathology.
Results: Using Protocol 1, both treatments with drugs and P10 significantly reduced
lung CFUs and showed a synergistical effect after 90 days preventing dissemination to liver
and spleen. The only relapse obtained with sulphamethoxazole after 90 days was controled
by P10 immunization. Using Protocol 2 basically the same results were obtained with
itraconazole or amphotericin B plus P10 immunization providing the best protection after
120 days. Using Protocol 1 after 90 days there was a tendency to decreased IL-4 and IL-10
and increased IFN-γ levels in animals immunized with P10. Using Protocol 2 the untreated
animal group showed higher levels of IL-4 and IL-10 whereas P10 immunization led to
higher IL-12 and IFN-γ levels alone or combined with chemotherapy. The association of
drug treatment and P10 immunization rendered large preserved areas in the lungs and fewer
granulomas with fewer yeasts cells. In general the association of drug treatment and P10
immunization was highly effective in the protection against intratracheal infection.
Conclusion: Synergistical protection using chemotherapy and P10 immunization
supports the adjuvant vaccination of patients with promiscuous peptides to reduce the time
of treatment and eventually control anergic cases of paracoccidioidomycosis.
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THE INNATE AND ACQUIRED IMMUNE RESPONSES IN
PARACOCCIDIOIDOMYCOSIS: DEFINING THE TARGETS FOR
IMMUNOMODULATION AND IMMUNOTHERAPY
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In this talk, the most recent knowledge on innate and acquired immunity of hosts against
Paracoccidioides brasiliensis (Pb) obtained through the isogenic murine model of resistance
and susceptibility to the fungus will be used to develop a rational for immunoprofilaxis or
immunomodulation. First it will be shown that a vigorous activation of innate immunity,
which is believed to protect hosts from pathogens, does not apply to PCM. A few studies
have shown that mannose receptors, complement receptors and laminin are involved in the
initial fungal-host cells interactions. Recent work in our lab suggests that Toll Like Receptor-
4 (TLR-4), more that TLR-2, functions as a fungal receptor and controls nitric oxide (NO)
synthesis but not fungal growth, therefore enhancing Pb infectivity. It has been also
demonstrated that NO has multiple antagonistic roles in PCM since this mediator is able to
regulate TNF-α synthesis, organization of granulomas, fungal multiplication and suppression
of cellular immunity. Unexpectedly, IFN-γ primed alveolar macrophages from susceptible
mice are able to control fungal multiplication due to enhanced synthesis of macrophage-
activating cytokines and elevated NO production. On the contrary, IFN-γ primed A/J
macrophages have a poor fungicidal ability concomitant with negligible amounts of NO due
to the enhanced synthesis of TGF-β. Furthermore, differently from expected, a less severe
PCM is observed after in vivo inhibition of leukotrienes or in LT-KO hosts. Recent studies
on NK cells depletion demonstrated their protective role to normal and T-cell deficient mice;
however, in the SCID phenotype NK cells are deleterious. In the same way, PMN leukocytes
can be either protective or not, depending on the genetic background of hosts. Altogether,
these results firmly indicate that a strong pro-inflammatory response at the innate phase of
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immunity does not lead to protective Th1 immunity but appears to activate vigorous regulatory
mechanisms which suppress cellular immunity needed to control the disease. Regarding
adaptative immunity, several data have shown that the Th1/Th2 model of immunity cannot
be unrestrictedly applied to PCM. It is classically accepted that type 1 cytokines are protective
whereas type 2 cytokines enhance PCM severity. However, IL-4 which has a deleterious role
in the C57BL/6 strain is protective to susceptible mice. PCM in IL-12 KO C57BL/6 mice
and in IL-12-depleted B10.A and A/J mice is very severe but early in vivo administration of
recombinant IL-12 to susceptible mice leads to severe inflammation of lung parenchyma.
Moreover, differently from other systemic mycosis, CD8+ T lymphocytes, more than CD4+
T cells exert the main control of Pb growth. Protective immunity in susceptible mice is mainly
CD8-mediated, whereas CD4+ T lymphocytes become anergic or deleted due to the intense
activation of innate immunity and activation of a CD8+ T-regulatory cell that suppresses
cellular immunity. In contrast, in resistant mice the sequential activation of Th1 and Th2
CD4+ T cells and type 1 CD8+ T lymphocytes leads to a regressive disease. Attempts to
vaccinate susceptible and resistant mice also brought very interesting results. In B10.A and
A/J mice, the previous s.c. inoculation of Pb induces an apparently self-healing infection
that can regulate a subsequent challenge. Interestingly, the i.p. and i.v. challenges of s.c.
vaccinated mice result respectively in immunoprotection and exacerbated disease. If the
challenge is done by the i.t. route immunoprotection is observed in susceptible but not in
resistant mice. As a whole, our knowledge on the innate and adaptative mechanisms of
immunity to Pb is still fragmentary but reveals the complexity of immune responses, and the
major influence of the genetic background of hosts. Our work underscores the notion that
activation of innate immunity can inhibit adaptative Th cell responses. As a corollary, a
strong Th1 inducing antigen should be avoided to not boost the already hyper-reactivity of
some susceptible hosts. Th2-inducing components can lead to exacerbated Th2 inflammatory
responses which were shown to be deleterious in some genetic patterns. In addition, individual
fungal components or peptides could not stimulate the cooperative action of CD4+ and CD8+
T cells and, more than that, could not stimulate the complex net of interactions which guarantee
efficient and sustained protective memory responses.
MS 2 - ECO-EPIDEMIOLOGY AND EVOLUTION OF  P. brasiliensis
NEW STRATEGIES AND OPPORTUNITIES FOR THE
ECOEPIDEMIOLOGICAL STUDY OF PARACOCCIDIOIDES
BRASILIENSIS: SENTINEL ANIMAL, MOLECULAR BIOLOGY AND
GEOPROCESSING
Eduardo Bagagli & Ligia Barrozo Simões
Departamento de Microbiologia e Imunologia, Instituto de Biociências, UNESP, Campus de
Botucatu, SP
The habitat of the saprobe mycelial form of P. brasiliensis that produces the infective
propagula is yet unknown, since the fungus is difficult to isolate from nature; the disease
Paracoccidioidomycosis (PCM) has a prolonged latency period and with no outbreaks. These
facts have impeded the adoption of preventive measures to avoid new infections. New
opportunities for the study and interpretation of its fungal ecology have emerged with the
integrated use of data and information from naturally infected armadillos, molecular
techniques that permit fungus detection in soil, spatial statistics and geoprocessing.
Natural infection of P. brasiliensis in armadillos (24 Dasypus novemcinctus, 03
Euphractus sexcimctus, 01 D. hybridus and 01 cabassous tatouay) was studied in the Botucatu
hyperendemic area, including one case from a fluvial island (Serrito Island, Barra Bonita
Dam), in which the animals have been geographically isolated from the rest of the continent
for more than 40 years. Eight animals (D. novemcinctus) were evaluated in captivity for
more than two years in relation to PCM development and fungal dissemination to the
environment. The fungus detection was carried out by tissue fragment culture, PCR with
species-specific primers for P. brasiliensis and histopathology. The fungal isolates were
characterized for their mycological, molecular and virulence profiles. Soil samples from the
environment and armadillo stools were evaluated for fungus presence by animal inoculation
and PCR. The area endemic for PCM, including the positive animal sites, was characterized
ecologically by its biotic and abiotic factors and with the use of Remote Sensing and
Geographic Information System.
Main results: the fungus was isolated in high frequency in the D. novemcinctus
armadillos; multiple infections can occur in the same animal; humans and armadillos may be
infected by the same ecopathogenotypes. Histopathological analysis showed rare granuloma
with few fungal elements, suggesting that armadillos can coexist with the pathogen, instead
of developing disease. The pathogen was also detected by PCR in the tissues and feces of the
animals as well as in soil samples from their burrows. In the species E. sexcimctus and C.
tatouay the fungus was not isolated and/or detected by PCR; but in D. hybridus the fungus
was detected by PCR in the spleen and mesentheric lymph nodes. Infected animals occur
mainly in humid disturbed riparian vegetation.
Spatial statistics demonstrated that the disease does not occur randomly in the study
area. Spatial regression among epidemiological data and environmental variables revealed
significant correlation between areas with clay soils cultivated by annual annual crops and
medium annual precipitation above 1400 mm. P. brasiliensis seems to prefer areas that
maintain humid conditions most of the time.
Support Fapesp (Process No. 02/00466-5; 01/13026-0; 02/4489-0R).
PARACOCCIDIOIDES BRASILIENSIS IN GEOLOGICAL TIMES
San-Blas, G.
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Life on earth started around 4,000 million years ago (Mya), when archaebacteria and
anaerobic bacteria appeared, probably derived from a hypothetical Last Universal Common
Ancestor (LUCA). Primitive eukaryotes arose 1,500 Mya, whereas fungi made their
appearance before the Cambrian explosion took place (600 Mya). Chytridiomycetes, aquatic
fungi, are the most primitive within the Kingdom Fungi, followed by Zygomycetes (500
Mya), Basidiomycetes (400 Mya), and Archaeoascomycetes of the type of Pneumocystis
carinii (320 Mya) or Schizosaccharomyces pombe (240 Mya). Euascomycetes evolved in
this geological time (e.g., Neurospora crassa and Sporothrix schenkii 180 Mya), while
Hemiascomycetes like Candida albicans and Saccharomyces cerevisiae made their appearance
around 130 and 80 Mya, respectively. As a point for reflexion, Homo sapiens has been
around only for the past 200 thousand years.
Evolutionary relationships among Histoplasma capsulatum, Blastomyces dermatitidis
and Paracoccidioides brasiliensis are under discussion. From protein coding genes,
Paracoccidioides seems to be the oldest lineage, but Histoplasma is the oldest one according
to 18S rRNA. Probably all three diverged around the same time. Divergence of Blastomyces
and Histoplasma occurred around 128 Mya, within the Mezosoic Period. Likewise, a mere
12.8 Mya is the probable divergence time for Coccidioides immitis and C. posadasii.
Setting the probable appearance of P. brasiliensis within the late Jurassic and early
Cretaceous period, geologically, what is today’s South America was close to Africa and
separated from current North America. Climate was cold. Could we speculate that P.
brasiliensis existed only as a saprophyte in the mycelial form? At the beginning of the Tertiary
era (Paleocene; 65 Mya) the temperature rose in such a way that if P. brasiliensis had already
able to shift to a yeast phase, it necessarily had to be forced into this morphology even as a
saprophyte. Coincidentally, this time is also the appearance time of the Order Xenarthra
(Glyptodon and its descendants, armadillos, among them), exclusively in South America,
one of whose species is Dasypus novemcinctus, nowadays proposed as the main reservoir of
P. brasiliensis in Nature. Body temperature in armadillos is approximately the same as the
median environmental temperature was in the Paleocene. Again, could we hypothesize that
by moving into a host, the fungus was able to live in a friendlier environment inasmuch as it
provided better and more stable nutritional sources, while enjoying a similar temperature?
During those early geological times, what is now the northern part of South America
(e.g., Colombia, Venezuela, northern region of Brazil) enjoyed a tropical, humid climate,
whereas current southern Brazil was mainly a desertic, arid region. Once more, could we
conjecture if, in addition to possible geographic barriers, climatic differences could drive the
currently detected cryptic species in P. brasiliensis?
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CRYPTIC SPECIATION AND RECOMBINATION IN THE FUNGUS
PARACOCCIDIOIDES BRASILIENSIS AS REVEALED BY GENE
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Introduction and Objectives - Paracoccidioides brasiliensis is the etiologic agent of
paracoccidioidomycosis, a disease confined to Latin America and of marked importance in
the endemic areas due to its frequency and severity. This species is considered to be clonal
according to mycological criteria and has been shown to vary in virulence.
Methods - To characterize natural genetic variation and reproductive mode in this fungus,
we analyzed P. brasiliensis phylogenetically in search of cryptic species and possible
recombination using concordance and nondiscordance of gene genealogies with respect to
phylogenies of eight regions in five nuclear loci.
Results - Our data indicate that this fungus consists of at least three distinct, previously
unrecognized species: S1 (Species 1 with 38 isolates), PS2 (phylogenetic species 2 with six
isolates) and PS3 (phylogenetic species 3 with 21 isolates). Genealogies of four of the regions
studied strongly supported the PS2 clade, composed of five Brazilian and one Venezuelan
isolate. The second clade, PS3, composed solely of 21 Colombian isolates, was strongly
supported by the a -tubulin genealogy. The remaining 38 individuals formed S1. Two of the
three lineages of P. brasiliensis, S1 and PS2, are sympatric across their range, suggesting
barriers to gene flow other than geographic isolation.
Conclusion - Our study provides the first evidence for a possible sexual reproduction
in P. brasiliensis S1, but does not rule it out in the other two species.
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